0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CDMO"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,850USDGBP
From
EUR$3,850USDGBP
From
EUR$3,850USDGBP
From
EUR$3,250USDGBP
EUR$4,850USDGBP
From
EUR$5,850USDGBP
Semi-Solid Dosage CDMO - Global Strategic Business Report - Product Thumbnail Image

Semi-Solid Dosage CDMO - Global Strategic Business Report

  • Report
  • July 2025
  • 464 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$2,500USDGBP
From
EUR$2,500USDGBP
Loading Indicator

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing. CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs). Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more